EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Getting It Right the Second Time: How Can we Optimize First‐Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Jonathan H Ryder iD, Shawnalyn W Sunagawa iD, Nathaniel J Rhodes iD, Trevor C Van Schooneveld iD, Jeremy E Tigh iD, Sean N Avedissian iD, Nicolas Cortes-Penfield iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-07 · 46 (7)

DOI: 10.1002/phar.70179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 10.06.2026. Verfasst von Jonathan H Ryder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: First Generation Cephalosporins, Skin Diseases, Bacterial, Soft Tissue Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimal cephalexin and cefadroxil dosing for skin and soft tissue infections (SSTIs) is unclear. We summarize clinical and pharmacokinetic/pharmacodynamic (PK/PD) data that compare dosing strategies for SSTIs. Additionally, we conduct population PK target attainment simulations for varying doses of cephalexin and cefadroxil for Staphylococcus aureus and Group A Streptococcus . Although some clinical data support lower doses in mild SSTIs, higher doses optimize PK/PD parameters in moderate–severe SSTIs, especially due to Staphylococcus aureus . Further prospective clinical and PK/PD studies, especially in obese adults, would be beneficial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

First Generation CephalosporinsSkin Diseases, BacterialSoft Tissue InfectionsHumansCefadroxilCephalexinDose-Response Relationship, DrugStaphylococcal InfectionsStaphylococcus aureus

Stichwörter der Autor:innen

cefadroxilcephalexinfirst‐generation cephalosporinspharmacokineticsskin and soft tissue infection

Substanzen

CefadroxilCephalexinFirst Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Pharmacy Practice, Midwestern University, Downers Grove, Illinois, USA.
  • Pharmacometrics Center of Excellence, Midwestern University, Downers Grove, Illinois, USA.
  • Department of Pharmacy, Good Samaritan Regional Medical Center, Corvallis, Oregon, USA.

ORCID-Profile: Jonathan H Ryder, Shawnalyn W Sunagawa, Nathaniel J Rhodes, Trevor C Van Schooneveld, Jeremy E Tigh, Sean N Avedissian, Nicolas Cortes-Penfield

Zitieren

APA

Ryder, J. H., Sunagawa, S. W., Rhodes, N. J., Van Schooneveld, T. C., Tigh, J. E., Avedissian, S. N., & Cortes-Penfield, N. (2026). Getting It Right the Second Time: How Can we Optimize First‐Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(7). https://doi.org/10.1002/phar.70179

Vancouver

Ryder JH, Sunagawa SW, Rhodes NJ, Van Schooneveld TC, Tigh JE, Avedissian SN, et al. Getting It Right the Second Time: How Can we Optimize First‐Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(7). doi:10.1002/phar.70179

BibTeX
@article{Ryder2026,
  author = {Ryder, Jonathan H and Sunagawa, Shawnalyn W and Rhodes, Nathaniel J and Van Schooneveld, Trevor C and Tigh, Jeremy E and Avedissian, Sean N and Cortes-Penfield, Nicolas},
  title = {Getting It Right the Second Time: How Can we Optimize First‐Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1002/phar.70179}
}
Kostenlos starten →